Crohn’s disease proteolytic microbiota enhances inflammation through PAR2 pathway in gnotobiotic mice

References

• Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol. 2015;12(4):205–19. doi:10.1038/nrgastro.2015.34.
   PubMed Web of Science ®Google Scholar
• Chang JT, Longo DL. Pathophysiology of inflammatory bowel diseases. N Engl J Med. 2020;383(27):2652–2664. doi:10.1056/NEJMra2002697.
   PubMed Web of Science ®Google Scholar
• Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015;12(12):720–727. doi:10.1038/nrgastro.2015.150.
   PubMed Web of Science ®Google Scholar
• Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, Panaccione R, Ghosh S, Wu JCY, Chan FKL, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769–2778. doi:10.1016/S0140-6736(17)32448-0.
   PubMed Web of Science ®Google Scholar
• Motta J, Magne L, Descamps D, Rolland C, Squarzoni–Dale C, Rousset P, Martin L, Cenac N, Balloy V, Huerre M, et al. Modifying the protease, antiprotease pattern by Elafin overexpression protects mice from colitis. Gastroenterology. 2011;140(4):1272–1282. doi:10.1053/j.gastro.2010.12.050.
   PubMed Web of Science ®Google Scholar
• Motta JP, Bermúdez-Humarán LG, Deraison C, Martin L, Rolland C, Rousset P, Boue J, Dietrich G, Chapman K, Kharrat P, et al. Food-grade bacteria expressing elafin protect against inflammation and restore colon homeostasis. Sci Transl Med. 2012;4(158). doi:10.1126/scitranslmed.3004212.
   PubMed Web of Science ®Google Scholar
• Steck N, Mueller K, Schemann M, Haller D. Bacterial proteases in IBD and IBS. Gut. 2012;61(11):1610–1618. doi:10.1136/gutjnl-2011-300775.
   PubMed Web of Science ®Google Scholar
• Carroll IM, Maharshak N. Enteric bacterial proteases in inflammatory bowel disease pathophysiology and clinical implications. World J Gastroenterol. 2013;19(43):7531–7543. doi:10.3748/wjg.v19.i43.7531.
   PubMed Web of Science ®Google Scholar
• Vergnolle N. Protease inhibition as new therapeutic strategy for GI diseases. Gut. 2016;65(7):1215–1224. doi:10.1136/gutjnl-2015-309147.
   PubMed Web of Science ®Google Scholar
• Van Spaendonk H, Ceuleers H, Witters L, Patteet E, Joossens J, Augustyns K, Lambeir A-M, De Meester I, De Man JG, De Winter BY. Regulation of intestinal permeability: the role of proteases. World J Gastroenterol. 2017;23(12):2106–2123. doi:10.3748/wjg.v23.i12.2106.
   PubMed Web of Science ®Google Scholar
• Vergnolle N. Review article: proteinase-activated receptors - novel signals for gastrointestinal pathophysiology. Alimentary Pharmacology & Therapeutics. 2000;14(3):257–266. doi:10.1046/j.1365-2036.2000.00690.x.
   PubMed Web of Science ®Google Scholar
• Mkaouar H, Mariaule V, Rhimi S, Hernandez J, Kriaa A, Jablaoui A, Akermi N, Maguin E, Lesner A, Korkmaz B, et al. Gut serpinome: emerging evidence in ibd. Int J Mol Sci. 2021;22(11):6088. doi:10.3390/ijms22116088.
   PubMed Web of Science ®Google Scholar
• Galipeau HJ, Caminero A, Turpin W, Bermudez-Brito M, Santiago A, Libertucci J, Constante M, Raygoza Garay JA, Rueda G, Armstrong S, et al. Novel fecal biomarkers that precede clinical diagnosis of ulcerative colitis. Gastroenterology. 2021;160(5):1532–1545. doi:10.1053/j.gastro.2020.12.004.
   PubMed Web of Science ®Google Scholar
• Edwinson AL, Yang L, Peters S, Hanning N, Jeraldo P, Jagtap P, Simpson JB, Yang T-Y, Kumar P, Mehta S, et al. Gut microbial β-glucuronidases regulate host luminal proteases and are depleted in irritable bowel syndrome. Nat Microbiol. 2022;7(5):680–694. doi:10.1038/s41564-022-01103-1.
   PubMed Web of Science ®Google Scholar
• Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI. Molecular analysis of commensal host-microbial relationships in the intestine. Science. 2001;291(5505):881–884. doi:10.1126/science.291.5505.881.
   PubMed Web of Science ®Google Scholar
• Natividad JM, Pinto-Sanchez MI, Galipeau HJ, Jury J, Jordana M, Reinisch W, Collins SM, Bercik P, Surette MG, Allen-Vercoe E, et al. Ecobiotherapy rich in firmicutes decreases susceptibility to colitis in a humanized gnotobiotic mouse model. Inflamm Bowel Dis. 2015;21(8):1883–1893. doi:10.1097/MIB.0000000000000422.
   PubMed Web of Science ®Google Scholar
• Hayes CL, Dong J, Galipeau HJ, Jury J, McCarville J, Huang X, Wang X-Y, Naidoo A, Anbazhagan AN, Libertucci J, et al. Commensal microbiota induces colonic barrier structure and functions that contribute to homeostasis. Sci Rep. 2018;8(1):1–14. doi:10.1038/s41598-018-32366-6.
   PubMedGoogle Scholar
• Jablaoui A, Kriaa A, Mkaouar H, Akermi N, Soussou S, Wysocka M, Wołoszyn D, Amouri A, Gargouri A, Maguin E, et al. Fecal serine protease profiling in inflammatory bowel diseases. Front Cell Infect Microbiol. 2020;10:21. doi:10.3389/fcimb.2020.00021.
   PubMed Web of Science ®Google Scholar
• Róka R, Rosztóczy A, Leveque M, Izbéki F, Nagy F, Molnár T, Lonovics J, Garcia–Villar R, Fioramonti J, Wittmann T, et al. A pilot study of fecal serine-protease activity: a pathophysiologic factor in diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol. 2007;5(5):550–555. doi:10.1016/j.cgh.2006.12.004.
   PubMed Web of Science ®Google Scholar
• Mills RH, Dulai PS, Vázquez-Baeza Y, Sauceda C, Daniel N, Gerner RR, Batachari LE, Malfavon M, Zhu Q, Weldon K, et al. Multi-omics analyses of the ulcerative colitis gut microbiome link bacteroides vulgatus proteases with disease severity. Nat Microbiol. 2022;7(2):262–276. doi:10.1038/s41564-021-01050-3.
   PubMed Web of Science ®Google Scholar
• Ashkar AA, Reid S, Verdu EF, Zhang K, Coombes BK. Interleukin-15 and NK1.1+ cells provide innate protection against acute Salmonella enterica serovar typhimurium infection in the gut and in systemic tissues. Infect Immun. 2009;77(1):214–222. doi:10.1128/IAI.01066-08.
   PubMed Web of Science ®Google Scholar
• Hernández-Chirlaque C, Aranda CJ, Ocón B, Capitán-Cañadas F, Ortega-González M, Carrero JJ, Suárez MD, Zarzuelo A, Sánchez de Medina F, Martínez-Augustin O. Germ-free and antibiotic-treated mice are highly susceptible to epithelial injury in DSS colitis. J Crohn’s Colitis. 2016;10(11):1324–1335. doi:10.1093/ecco-jcc/jjw096.
   Google Scholar
• De Palma G, Lynch MDJ, Lu J, Dang VT, Deng Y, Jury J, Umeh G, Miranda PM, Pigrau Pastor M, Sidani S, et al. Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice. Sci Transl Med. 2017;9(379). doi:10.1126/scitranslmed.aaf6397.
   Web of Science ®Google Scholar
• Caminero A, McCarville JL, Zevallos VF, Pigrau M, Yu XB, Jury J, Galipeau HJ, Clarizio AV, Casqueiro J, Murray JA, et al. Lactobacilli degrade wheat amylase trypsin inhibitors to reduce intestinal dysfunction induced by immunogenic wheat proteins. Gastroenterology. 2019;156(8):2266–2280. doi:10.1053/j.gastro.2019.02.028.
   PubMed Web of Science ®Google Scholar
• Jiménez-Saiz R, Anipindi VC, Galipeau H, Ellenbogen Y, Chaudhary R, Koenig JF, Gordon ME, Walker TD, Mandur TS, Abed S, et al. Microbial regulation of enteric eosinophils and its impact on tissue remodeling and Th2 Immunity. Front Immunol. 2020;11. doi:10.3389/fimmu.2020.00155.
   PubMed Web of Science ®Google Scholar
• Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature. 2001;410(6824):37–40. doi:10.1038/35065000.
   PubMed Web of Science ®Google Scholar
• Yu H, Lin L, Zhang Z, Zhang H, Hu H. Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study. Curr Signal Transduct Ther. 2020;5(1). doi:10.1038/s41392-020-00312-6.
   Google Scholar
• Sánchez-Fidalgo S, Villegas I, Rosillo MÁ, Aparicio-Soto M, de la Lastra CA. Dietary squalene supplementation improves DSS-induced acute colitis by downregulating p38 MAPK and NFkB signaling pathways. Mol Nutr Food Res. 2015;59(2):284–292. doi:10.1002/mnfr.201400518.
   PubMed Web of Science ®Google Scholar
• Fyfe M, Bergström M, Aspengren S, Peterson A. PAR-2 activation in intestinal epithelial cells potentiates interleukin-1β-induced chemokine secretion via MAP kinase signaling pathways. Cytokine. 2005;31(5):358–367. doi:10.1016/j.cyto.2005.06.004.
   PubMed Web of Science ®Google Scholar
• Yoshida N, Katada K, Handa O, Takagi T, Kokura S, Naito Y, Mukaida N, Soma T, Shimada Y, Yoshikawa T, et al. Interleukin-8 production via protease-activated receptor 2 in human esophageal epithelial cells. Int J Mol Med. 2007;19. doi:10.3892/ijmm.19.2.335.
   Web of Science ®Google Scholar
• Keir ME, Yi T, Lu TT, Ghilardi N. The role of IL-22 in intestinal health and disease. J Exp Med. 2020;217(3). doi:10.1084/jem.20192195.
   PubMed Web of Science ®Google Scholar
• Andoh A, Zhang Z, Inatomi O, Fujino S, Deguchi Y, Araki Y, Tsujikawa T, Kitoh K, Kim–Mitsuyama S, Takayanagi A, et al. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology. 2005;129(3):969–984. doi:10.1053/j.gastro.2005.06.071.
   PubMed Web of Science ®Google Scholar
• Schmechel S, Konrad A, Diegelmann J, Glas J, Wetzke M, Paschos E, Lohse P, Göke B, Brand S. Linking genetic susceptibility to Crohnʼs disease with Th17 cell function: iL-22 serum levels are increased in Crohnʼs disease and correlate with disease activity and IL23R genotype status. Inflamm Bowel Dis. 2008;14(2):204–212. doi:10.1002/ibd.20315.
   PubMed Web of Science ®Google Scholar
• Højen JF, Kristensen MLV, McKee AS, Wade MT, Azam T, Lunding LP, de Graaf DM, Swartzwelter BJ, Wegmann M, Tolstrup M, et al. IL-1R3 blockade broadly attenuates the functions of six members of the IL-1 family, revealing their contribution to models of disease. Nat Immunol. 2019;20(9):1138–1149. doi:10.1038/s41590-019-0467-1.
   PubMed Web of Science ®Google Scholar
• Schwerd T, Bryant RV, Pandey S, Capitani M, Meran L, Cazier J-B, Jung J, Mondal K, Parkes M, Mathew CG, et al. NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease. Mucosal Immunol. 2018;11(2):562–574. doi:10.1038/mi.2017.74.
   PubMed Web of Science ®Google Scholar
• Lu Y, Li X, Liu S, Zhang Y, Zhang D. Toll-like receptors and inflammatory bowel disease. Front Immunol. 2018;9:72. doi:10.3389/fimmu.2018.00072.
   PubMed Web of Science ®Google Scholar
• Pascal V, Pozuelo M, Borruel N, Casellas F, Campos D, Santiago A, Martinez X, Varela E, Sarrabayrouse G, Machiels K, et al. A microbial signature for Crohn’s disease. Gut. 2017;66(5):813–822. doi:10.1136/gutjnl-2016-313235.
   PubMed Web of Science ®Google Scholar
• Vich Vila A, Imhann F, Collij V, Jankipersadsing SA, Gurry T, Mujagic Z, Kurilshikov A, Bonder MJ, Jiang X, Tigchelaar EF, et al. Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome. Sci Transl Med. 2018;10(472):1–11. doi:10.1126/scitranslmed.aap8914.
   Web of Science ®Google Scholar
• Franzosa EA, Sirota-Madi A, Avila-Pacheco J, Fornelos N, Haiser HJ, Reinker S, Vatanen T, Hall AB, Mallick H, McIver LJ, et al. Gut microbiome structure and metabolic activity in inflammatory bowel disease. Nat Microbiol. 2019;4(2):293–305. doi:10.1038/s41564-018-0306-4.
   PubMed Web of Science ®Google Scholar
• Lee M, Chang EB. Inflammatory Bowel Diseases (IBD) and the microbiome—searching the crime scene for clues. Gastroenterology. 2021;160(2):524–537. doi:10.1053/j.gastro.2020.09.056.
   PubMed Web of Science ®Google Scholar
• Carroll IM, Ringel-Kulka T, Ferrier L, Wu MC, Siddle JP, Bueno L, Ringel Y. Fecal protease activity is associated with compositional alterations in the intestinal microbiota. Plos One. 2013;8(10):e78017. doi:10.1371/journal.pone.0078017.
   PubMed Web of Science ®Google Scholar
• Lloyd-Price J, Arze C, Ananthakrishnan AN, Schirmer M, Avila-Pacheco J, Poon TW, Andrews E, Ajami NJ, Bonham KS, Brislawn CJ, et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature. 2019;569(7758):655–662. doi:10.1038/s41586-019-1237-9.
   PubMed Web of Science ®Google Scholar
• Rajilić-Stojanović M, Shanahan F, Guarner F, De Vos WM. Phylogenetic analysis of dysbiosis in ulcerative colitis during remission. Inflamm Bowel Dis. 2013;19(3):481–488. doi:10.1097/MIB.0b013e31827fec6d.
   PubMed Web of Science ®Google Scholar
• Jangid A, Fukuda S, Seki M, Horiuchi T, Suzuki Y, Taylor TD, Ohno H, Prakash T. Association of colitis with gut-microbiota dysbiosis in clathrin adapter AP-1B knockout mice. Plos One. 2020;15(3):e0228358. doi:10.1371/journal.pone.0228358.
   PubMed Web of Science ®Google Scholar
• Hoy B, Löwer M, Weydig C, Carra G, Tegtmeyer N, Geppert T, Schröder P, Sewald N, Backert S, Schneider G, et al. Helicobacter pylori HtrA is a new secreted virulence factor that cleaves E-cadherin to disrupt intercellular adhesion. EMBO Rep. 2010;11(10):798. doi:10.1038/embor.2010.114.
   PubMed Web of Science ®Google Scholar
• Jones CH, Bolken TC, Jones KF, Zeller GO, Hruby DE, Tuomanen EI. Conserved DegP protease in gram-positive bacteria is essential for thermal and oxidative tolerance and full virulence in Streptococcus pyogenes. Infect Immun. 2001;69(9):5538. doi:10.1128/IAI.69.9.5538-5545.2001.
   PubMed Web of Science ®Google Scholar
• Kajikawa H, Yoshida N, Katada K, Hirayama F, Handa O, Kokura S, Naito Y, Yoshikawa T. Helicobacter pylori activates gastric epithelial cells to produce interleukin-8 via protease-activated receptor 2. Digestion. 2007;76(3–4):248–255. doi:10.1159/000113041.
   PubMed Web of Science ®Google Scholar
• Hugot J, Chamaillard M, Zouali H, Lesage S, Cézard J-P, Belaiche J, Almer S, Tysk C, O’Morain CA, Gassull M, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature. 2001;411(6837):599–603. doi:10.1038/35079107.
   PubMed Web of Science ®Google Scholar
• Inohara N, Nuñez GN. Intracellular proteins involved in inflammation and apoptosis. Nat Rev Immunol. 2003;3(5):371–382. doi:10.1038/nri1086.
   PubMed Web of Science ®Google Scholar
• Turpin W, Goethel A, Bedrani L, Croitoru K. Determinants of IBD heritability: genes, bugs, and more. Inflamm Bowel Dis. 2018;24(6):1133–1148. doi:10.1093/ibd/izy085.
   PubMed Web of Science ®Google Scholar
• Krachler AM, Woolery AR, Orth K. Host–pathogen interactions: manipulation of kinase signaling by bacterial pathogens. J Cell Biol. 2011;195(7):1083. doi:10.1083/jcb.201107132.
   PubMed Web of Science ®Google Scholar
• Vergnolle N. Clinical relevance of proteinase activated receptors (PARs) in the gut. Gut. 2005;54(6):867–874. doi:10.1136/gut.2004.048876.
   PubMed Web of Science ®Google Scholar
• Caminero A, McCarville JL, Galipeau HJ, Deraison C, Bernier SP, Constante M, Rolland C, Meisel M, Murray JA, Yu XB, et al. Duodenal bacterial proteolytic activity determines sensitivity to dietary antigen through protease-activated receptor-2. Nat Commun. 2019;10(1):1–14. doi:10.1038/s41467-019-09037-9.
   PubMedGoogle Scholar
• Harvey RF, Bradshaw JM. A simple index of Crohn’s-disease activity. Lancet. 1980;315(8167):514. doi:10.1016/S0140-6736(80)92767-1.
   Google Scholar
• Sandborn WJ, Feagan BG, Hanauer SB, Lochs H, Löfberg R, Modigliani R, Present DH, Rutgeerts P, Schölmerich J, Stange EF, et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn’s disease. Gastroenterology. 2002;122(2):512–530. doi:10.1053/gast.2002.31072.
   PubMed Web of Science ®Google Scholar
• Slack E, Hapfelmeier S, Stecher B, Velykoredko Y, Stoel M, Lawson MAE, Geuking MB, Beutler B, Tedder TF, Hardt W-D, et al. Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. Science. 2009;325(5940):617–620. doi:10.1126/science.1172747.
   PubMed Web of Science ®Google Scholar
• Liang HPH, Kerschen EJ, Hernandez I, Basu S, Zogg M, Botros F, Jia S, Hessner MJ, Griffin JH, Ruf W, et al. EPCR-dependent PAR2 activation by the blood coagulation initiation complex regulates LPS-triggered interferon responses in mice. Blood. 2015;125(18):2845–2854. doi:10.1182/blood-2014-11-610717.
   PubMed Web of Science ®Google Scholar
• Stearns JC, Davidson CJ, McKeon S, Whelan FJ, Fontes ME, Schryvers AB, Bowdish DME, Kellner JD, Surette MG. Culture and molecular-based profiles show shifts in bacterial communities of the upper respiratory tract that occur with age. Isme J. 2015;9(5):1246–1259. doi:10.1038/ismej.2014.250.
   PubMed Web of Science ®Google Scholar
• Bartram AK, Lynch MDJ, Stearns JC, Moreno-Hagelsieb G, Neufeld JD. Generation of multimillion-sequence 16S rRNA gene libraries from complex microbial communities by assembling paired-end Illumina reads. Appl Environ Microbiol. 2011;77:3846–3852.
   PubMed Web of Science ®Google Scholar
• Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet j. 2011;17(1):10. doi:10.14806/ej.17.1.200.
   Google Scholar
• Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJA, Holmes SP. DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods. 2016;13(7):581–583. doi:10.1038/nmeth.3869.
   PubMed Web of Science ®Google Scholar
• Price MN, Dehal PS, Arkin AP, Poon AFY. FastTree 2 – approximately maximum-likelihood trees for large alignments. Plos One. 2010;5(3):e9490. doi:10.1371/journal.pone.0009490.
   PubMed Web of Science ®Google Scholar
• McMurdie PJ, Holmes S, Watson M. Phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. Plos One. 2013;8(4):e61217. doi:10.1371/journal.pone.0061217.
   PubMed Web of Science ®Google Scholar
• Langille MGI, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA, Clemente JC, Burkepile DE, Vega Thurber RL, Knight R, et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol. 2013;31(9):814–821. doi:10.1038/nbt.2676.
   PubMed Web of Science ®Google Scholar
• Douglas GM, Maffei VJ, Zaneveld JR, Yurgel SN, Brown JR, Taylor CM, Huttenhower C, Langille MGI. Picrust2 for prediction of metagenome functions. Nat Biotechnol. 2020;38(6):685–688. doi:10.1038/s41587-020-0548-6.
   PubMed Web of Science ®Google Scholar
• Wixon J, Kell D. The kyoto encyclopedia of genes and genomes—KEGG. Yeast. 2000;17:48–55.
   PubMed Web of Science ®Google Scholar
• Cholet F, Ijaz UZ, Smith CJ. Differential ratio amplicons (R amp) for the evaluation of RNA integrity extracted from complex environmental samples. Environ Microbiol. 2019;21(2):827–844. doi:10.1111/1462-2920.14516.
   PubMed Web of Science ®Google Scholar
• Makui H, Soares RJ, Jiang W, Constante M, Santos MM. Contribution of Hfe expression in macrophages to the regulation of hepatic hepcidin levels and iron loading. Blood. 2005;106(6):2189–2195. doi:10.1182/blood-2005-02-0629.
   PubMed Web of Science ®Google Scholar
• Chandrabalan A, Firth A, Litchfield RB, Appleton CT, Getgood A, Ramachandran R. Human osteoarthritis knee joint synovial fluids cleave and activate Proteinase-Activated Receptor (PAR) mediated signaling. Sci Rep. 2023;13. doi:10.1038/s41598-023-28068-3.
   PubMed Web of Science ®Google Scholar
• Ramachandran R, Mihara K, Chung H, Renaux B, Lau CS, Muruve DA, DeFea KA, Bouvier M, Hollenberg MD. Neutrophil elastase acts as a biased agonist for proteinase-activated receptor-2 (PAR 2). J Biol Chem. 2011;286(28):24638–24648. doi:10.1074/jbc.M110.201988.
   PubMed Web of Science ®Google Scholar
• Mihara K, Ramachandran R, Saifeddine M, Hansen KK, Renaux B, Polley D, Gibson S, Vanderboor C, Hollenberg MD. Thrombin-mediated direct activation of proteinase-activated receptor-2: another target for thrombin signaling. Mol Pharmacol. 2016;89(5):606–614. doi:10.1124/mol.115.102723.
   PubMed Web of Science ®Google Scholar